|
HS Code |
499820 |
| Productname | Trimethylsilyl Bromoacetate |
| Casnumber | 40245-62-3 |
| Molecularformula | C5H11BrO2Si |
| Molecularweight | 211.13 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Boilingpoint | 96-97°C at 17 mmHg |
| Density | 1.33 g/mL at 25°C |
| Refractiveindex | 1.4410-1.4430 |
| Purity | Typically ≥ 97% |
| Solubility | Soluble in organic solvents |
| Smiles | C[Si](C)(C)OC(=O)CBr |
| Storagetemperature | 2-8°C (Refrigerated) |
| Synonyms | TMS Bromoacetate |
| Inchikey | QXJRWPZZTBLXCP-UHFFFAOYSA-N |
| Hazardclass | Corrosive |
As an accredited Trimethylsilyl Bromoacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Trimethylsilyl Bromoacetate, 25g, is packaged in a sealed amber glass bottle with a tamper-evident cap and safety labeling. |
| Shipping | Trimethylsilyl Bromoacetate is shipped in tightly sealed containers under cool, dry conditions. It should be protected from moisture and stored away from incompatible substances. This chemical is typically dispatched as a hazardous material, requiring appropriate labeling and adherence to transport regulations for flammable and corrosive substances. Handle with suitable personal protective equipment. |
| Storage | Trimethylsilyl Bromoacetate should be stored in a tightly sealed container, under an inert atmosphere such as nitrogen or argon, and kept in a cool, dry, and well-ventilated area. Protect it from moisture, heat, and direct sunlight. Store it away from oxidizing agents, acids, and bases to prevent hazardous reactions. Proper chemical safety protocols should always be followed. |
Applications of Trimethylsilyl Bromoacetate in Industrial ManufacturingAs a dedicated manufacturer, we supply Trimethylsilyl Bromoacetate (TMSBA) for critical downstream industrial synthesis applications. Our focus is on sectors where this reagent brings proven value to complex organic transformations, enabling controlled protection, esterification, and intermediate synthesis in regulated production environments. Below we highlight verified application scenarios, including reference to compliance frameworks, typical usage levels, process roles, and commercial end products. 1. Active Pharmaceutical Ingredient (API) Intermediate SynthesisTMSBA serves as a key esterification and alkylation agent for producing protected intermediates, such as α-bromoacetate esters, in the small molecule API supply chain. Many pharmaceutical manufacturers leverage this material for constructing bromoacetate-protected building blocks required in multi-step synthesis of antivirals, cardiovascular compounds, and CNS drugs. The precise control over the introduction and subsequent removal of protective trimethylsilyl groups supports demands for stringent impurity profiles, critical for regulatory approval of finished APIs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptide and Oligonucleotide SynthesisPeptide and nucleotide contract manufacturers use TMSBA for the introduction of protected bromoacetate motifs onto side chains or nucleoside analogs, which are transiently necessary for complex solid-phase or solution-phase assembly. This protected group chemistry aids in minimizing side reactions during backbone elongation and serves as a handle for subsequent orthogonal deprotection, vital to the mass production of high-purity peptides and therapeutic oligos. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Intermediate ManufacturingAgrochemical suppliers integrate TMSBA into their chemical synthesis routes to access protected esters and bromoacetate intermediates central to the construction of advanced herbicide, insecticide, and fungicide molecules. The material supports precise management of reactivity in compounds sensitive to hydrolysis or nucleophilic attack, functioning as a temporizing group in multistep transformations to maximize process yield and minimize cross-contamination. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Materials and Specialty Polymer SynthesisIn specialty polymer and advanced materials production, manufacturers turn to TMSBA for selective modification of macromonomers and fine-tuning molecular architectures. Especially in the electronics, coatings, and optical materials sectors, engineered bromoacetate motifs introduce pendant functional groups for post-polymerization crosslinking or targeted surface modification, enabling next-generation material properties such as higher dielectric performance or tailored hydrophobicity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Building Block ProductionCommercial fine chemical houses incorporate TMSBA in their routes for manufacturing α-bromoacetate and silyl-protected acid reagents. These compounds serve as essential building blocks for contract synthesis and catalogue supply, where precise control over functional group protection and subsequent release is paramount to supporting end-user needs in medicinal, agrochemical, and research chemistry sectors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Trimethylsilyl Bromoacetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in a specialty chemical plant, you get to know which products make life easier for research labs, process chemists, and fine chemical developers. Trimethylsilyl bromoacetate grabs attention for more than just its structure or purity. You see it at the intersection of academic curiosity and industrial ambition. As engineers and chemists who bring batches to life, we understand both the subtle behaviors in solution and the reliability it can deliver batch after batch.
From a manufacturer’s viewpoint, figuring out what makes bromoacetate reagents tick takes real experience. Trimethylsilyl bromoacetate lays down some special traits that folks in multistep synthesis recognize quickly. Take its role as an alkylating agent: it brings the reactivity of a bromoacetate but with silyl protection that broadens your toolbox. Over the years, we’ve fielded questions from process teams wondering about downstream protection-deprotection logistics, solvent compatibility, and product stability. We see the practical questions and know what happens at the bench as people move beyond catalog descriptions.
Trimethylsilyl bromoacetate synthesis tests how closely you can hold to water-free conditions and low temperatures. Step outside those lines, and the final purity goes off fast. We use both gas chromatography and NMR for every lot. Impurities introduce problems you can’t ignore in sensitive synthesis. The bromo group stands ready to react, but the trimethylsilyl cap adds enough bulk to offer stability during transport and storage if you lock in inert atmospheres and clean handling practices.
Before bottling, each batch runs through drying columns. Even trace water leads to hydrolysis, which defeats its most attractive feature as a protected bromoacetate. The material flows off slightly viscous, clear, and with that distinct ester odor. Quality matters far beyond purity on the label; ease of handling under nitrogen, resistance to light, and real-world stability during lab manipulation define whether a product can carry its weight in project timelines.
Most labs want purity above 98%, and we keep specifications tight for both active compound and residue on ignition. Moisture levels below 0.05% have proven necessary to maintain shelf life and performance. Color and absence of particulates stay consistent batch-to-batch; it’s a visual assurance but tells you a lot about upstream process control. Over the years, we’ve worked with scale-up groups who push loading to the edge while maintaining reactivity in cross-coupling or alkylation sequences. This is never just about hitting numbers on a lot certificate—it’s about whether downstream steps keep up.
Our drums and bottles use high-integrity seals and PTFE-lined caps. While many chemicals can tolerate lesser packaging, bromoacetate derivatives like this degrade in plain polyethylene. We have moved to argon-flushed containers for critical shipments, sometimes with individual ampules for research clients who cannot risk cross-contamination.
You notice right away how TMS bromoacetate separates itself from simple methyl or ethyl analogs. The silyl group blocks unnecessary side-reactions, so it gives synthetic chemists the chance to work in more varied solvents and temperatures—far broader options than you get from a basic bromoacetate. Some analogs decompose or polymerize, but this one generally holds up, provided you respect moisture and light.
During many conversations with researchers, we learned that direct bromoacetate alkylation creates cleanup headaches with unwanted overreactions or hydrolyzed junk. On a larger scale, these side-products challenge cleanup, waste handling, and ultimately, reproducibility. Trimethylsilyl bromoacetate helps cut those problems down because the protective group slows unwanted reactivity until you actively trigger it. As a manufacturer, seeing less returned product and fewer emergency questions on storage or shelf life is a relief.
Unlike methyl bromoacetate, which might break down upon exposure to base or even atmospheric moisture, the silylated compound endures more rigorous workups. Our own technical teams have seen this first-hand, especially with clients using formal deprotection steps or working under pressure for time-sensitive procedures. You get more shots on goal when your key reagent arrives intact and dependable.
Trimethylsilyl bromoacetate serves as an intermediate in diverse settings—academic synthesis, pharmaceutical R&D, and pilot-scale process labs. Reagent suppliers and inventory managers often spot demand spikes as research pivots toward medicinal chemistry projects or process intensification involving glycosylation and esterification. What makes this compound particularly valuable is its combination of a transferable bromo group and the stability offered by the silyl protecting group.
Research teams in nucleoside or oligonucleotide synthesis often look for a bromoacetate with enhanced shelf stability and fewer byproduct complications in downstream steps. That’s where TMS bromoacetate comes in. Our partners developing new kinase inhibitors or incorporating unusual building blocks into larger scaffolds ask for it specifically. The alternative is risking more time on flash columns or preparative HPLC, separating hydrolysis products from target molecules.
In peptide synthesis, you sometimes encounter difficulties adding modified residues or masking reactive sites that may otherwise trigger side reactions. With TMS bromoacetate, installation of bromoacetate motifs can proceed under milder conditions. The trimethylsilyl group stays in place during coupling, and you can remove it cleanly with a fluoride source at the right stage—our direct feedback from process scale-ups in peptide-based drug development underscores its utility there.
In carbohydrate chemistry, researchers often prefer this silyl-protected bromoacetate when constructing protected intermediates en route to complex oligosaccharides. We’ve supported teams that ran into persistent issues with traditional unprotected bromoacetates decomposing or reacting before the intended coupling. TMS bromoacetate holds up better, giving more control when timing and selectivity matter.
Academic labs have used it to introduce esterified blocks for combinatorial libraries, harnessing the reactivity of the bromo group while relying on the predictable deprotection step to reveal carboxylate when needed. This organization of steps cuts risk, in our experience, particularly for newer researchers who haven’t worked out all the kinks in a multistep route.
People ask if TMS bromoacetate really needs so much fuss—sealing, inert gas, careful temperature control. Our answer is always yes, and not from some misplaced affection for complexity. In manufacturing, we’ve watched slow leaks or even a missed glove touch ruin the utility of a whole container. The chemistry relies on exclusion of water and oxygen. If you run a plant, you live this every day: a few ppm water, ambient air, and the ester starts to split; workup yields crash or downstream reactions stop cold.
We run desiccant beds, pressure checks, and real gas analytics to keep production risk low. Packing, too, requires close handling—some years back, a run of bottles closed without argon swept headspace came back with hydrolysis issues. You learn fast in this business that shortcuts cost more time and credibility than they save. New employees get trained on why gloves, lined caps, and double-sealing are not just for show. If they see a creamy precipitate or detect off-odors, we encourage them to hold everything for review.
Clients occasionally ask for bulk shipments or custom-formulated solutions with TMS bromoacetate added directly to chosen solvents. We’ve accommodated these requests, but always recommend transfer by syringe under inert gas, or at least in a glove box. If your team plans to scale up, stick to glass or PTFE lines—this ester leaches plasticizers and degrades in softer polymers. Every step, from reactor addition to quench, plays into the final yield and clean-up work that follows.
Trimethylsilyl bromoacetate’s demand follows both graduate thesis cycles and pharma innovation calendars. We see orders ramp up when a blockbuster substance hits the late stage clinical trial phase, and then again at the start of new synthetic methodology trends. As a maker, you have to watch both global bromine prices and silyl chloride availability—shortages or regulation shifts cascade through cost and lead time. About five years ago, a sharp uptick in demand outpaced available raw material, pushing all manufacturers to scrutinize their supply chains. We responded by qualifying new bromine sources and adapting distillation setups to achieve the same purity.
Our process engineering teams run quarterly review meetings to look at reaction yields, waste streams, and energy use. TMS bromoacetate distills under reduced pressure under tight quality controls. We log run temperatures and GC chromatograms, discussing in real time which changes reduce decomposition or speed up final crystallization. While working with outside partners, we’ve shared some know-how both upstream and downstream, swapping lessons on scale-up or analytical testing. The technical community here is close knit; mutual success builds over years, not months.
Shipping TMS bromoacetate internationally throws up extra headaches, particularly in customs delays or temperature control lapses. We heard from a European client who received containers with sticky caps—thermal cycling during air transit let condensation restart hydrolysis. In response, our logistics moved toward layered packing and timed-release cold packs, and we increased air-evacuation at fill to slow down any initial humidity uptake. User feedback keeps us honest, and we replace any substandard shipment quickly.
Long-term storage works best in amber glass with a wide Teflon seal and argon headspace. Some research customers ask why. From direct observation, UV light hastens breakdown, and trace metals from closures catalyze hydrolysis and polymerization. Open flasks even for weighing cause rapid odor changes, signaling product drift. By storing it right from the start, users find the reagent remains reactive for much longer, improving budget planning for infrequent projects.
From time to time, research groups request storage at minus twenty Celsius or even colder. We point out this can slow down unwanted reactions, but the compound flows better at room temperature, so decanting becomes trickier. The key is always to minimize open exposure—our technical bulletins reflect practices learned on the line. Proper handling protects not just the product, but also minimizes waste disposal issues tied to decomposed or contaminated material.
We regularly adjust protocols as researchers or process teams discover new applications. As a manufacturer, you never want to dismiss even low-volume custom requests—they point to emerging methodologies. In the past, we collaborated with a team working on photo-switchable molecules who found TMS bromoacetate improved yield consistency under their atypical conditions, leading us to change filtration protocol and offer a lower particulate grade.
Routine feedback from industry also shapes our packaging. Several clients in peptide synthesis wanted ergonomic squeeze bottles, but with inert headspace. We modified fill lines and sourced new bottles that keep the product stable while making it easier to dispense under argon blanket. The real-world result cuts down lost product in the transfer, which matters for value and safety.
Scalability presents another point for ongoing improvement. We once spent months tuning reactor charge rates, jacket temperatures, and solvent gradients to preserve the silyl group while maximizing bromoacetic acid conversion. Even minor changes in agitation speed or valve timing show up on downstream purity analytics, so we chart each lot and hold regular review meetings after every multiton campaign.
Making and bottling TMS bromoacetate, we think seriously about waste and exposure. Bromoacetates generate persistent halogen-containing waste, and every ounce neutralized instead of dumped saves trouble downriver. We built in recycling pathways for bromide and silylated distillation residues, and treat all tank washings in approved in-plant facilities.
Floor teams wear double gloves and full-face shields, not as a box-checking exercise but because the compound burns on skin or mucosa and has a sharp, penetrating odor. Spills draw a response call and immediate cleanup, sometimes with dry ice quench and solvent flush. We see that even lab workers with years of organic synthesis behind them sometimes underestimate physical or inhalation hazards; training, reminder posters, and positive reinforcement for careful work culture make the difference.
People working for production companies do not get second chances often. Handling a moisture- and air-sensitive, moderately toxic compound daily, you learn to take practical measures seriously. We have integrated real-time air monitoring and explicit solvent compatibility charts on the production floor, which keeps both operators and the batch itself safer.
One difference you notice serving both specialist and generalist users of trimethylsilyl bromoacetate lies in their questions. Professional chemists often want details on upstream precursor testing, water control, or trace heavy metals. Others ask simply if they’ll need extra columns for purification. With decades of combined experience, we answer both, sharing the details that only come from making, rather than buying, each lot.
We value transparency not because it sounds good, but because it reduces surprises, site waste, or batch delays. Users who call about unexplained side-products or odd spectral results often teach us something new. These partnerships go beyond paperwork. When someone runs into trouble with a reaction—low conversion, strange precipitates—we swap notes and, if needed, reformulate on a custom basis.
Connections between process plant and bench chemist have pulled our standards higher year on year. Keeping real data on file, reviewing results with both quality and technical groups, and passing lessons along to new hires—all these steps pay off in better product and safer use around the world.
The road ahead for trimethylsilyl bromoacetate manufacturing looks challenging and promising. Regulations tighten across many regions regarding bromine and silyl reagents, which means more documentation and close attention to supply chain reliability. We keep extra feedstock inventory in strategic locations. Modular reactors and updated purification setups help cover unexpected market direction changes or raw material gaps.
Research keeps driving new uses. As more projects require finely tuned protecting group strategies, chemists need options with the right balance of availability, protection, and reactivity. We listen to clients about packaging, scale, and required documentation. Our lab development group studies published reports and client feedback so we can improve protocols in real time, from loading to final work-up.
Stepping into the future, we see collaborative development projects with biotech and advanced material teams as key. Manufacturing’s greatest asset here comes from close knowledge of the product’s behavior, challenges, and practical advantages. Our experience making, bottling, shipping, and troubleshooting trimethylsilyl bromoacetate every week shapes how we help researchers solve the synthesis puzzles ahead.